U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Skip to Main Navigation
Skip to Page Content
Skip to Atlas Navigation

Eye, Optic Nerve - Degeneration

Image of optic nerve degeneration in the eye from a female B6C3F1 mouse in a chronic study
Eye, Optic nerve - Degeneration in a female B6C3F1 mouse from a chronic study. Optic nerve degeneration (arrow) is characterized by scattered clear vacuoles.
Figure 1 of 2
Image of optic nerve degeneration in the eye from a female B6C3F1 mouse in a chronic study
Eye, Optic nerve - Degeneration in a female B6C3F1 mouse from a chronic study (higher magnification of Figure 1). There are scattered clear vacuoles (arrow) in the optic nerve.
Figure 2 of 2
next arrow


Optic nerve degeneration can result from various causes, including increased intraocular pressure, compromised vascular supply, and physical trauma (e.g., from retro-orbital bleeding procedures). Since the optic nerve is composed of the axons of retinal ganglion cells, primary lesions in the retina (especially those affecting the ganglion cell and nerve fiber layers) frequently result in concurrent optic nerve pathology, including degeneration. Since the optic nerve is an extracranial white matter tract of the brain, optic nerve degeneration can also be a "descending" change secondary to lesions in the brain. Although the extent can vary with rodent strain, optic nerve axonal degeneration and loss can also be an age-related incidental change in rats and mice. Optic nerve degeneration of uncertain etiology has also been reported as a spontaneous change in adult rats.

Optic nerve degeneration can be characterized by scattered clear vacuoles (as in Figure 1image opens in a pop-up window and Figure 2image opens in a pop-up window ), which often contain swollen, pale eosinophilic fragmented axons and/or myelin debris. In more chronic cases, there can be decreased numbers of axons, decreased diameter of the remaining axons, and pial septa thickening. The loss of axons may lead to decreased overall diameter of the nerve. Variable glial cell proliferation and/or macrophage infiltration may occur concurrently.


Optic nerve degeneration should be diagnosed and assigned a severity grade. The presence of optic nerve degeneration should prompt careful examination of the retina (especially the ganglion cell and nerve fiber layers) for concurrent pathology. Associated lesions (e.g., inflammation) should be diagnosed separately.


Cepurna WO, Kayton RJ, Johnson EC, Morrison JC. 2005. Age related optic nerve axonal loss in adult brown Norway rats. Exp Eye Res 80:877-884.
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/15939045

John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, Roderick TH, Heckenlively JR. 1998. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39:951-962.
Abstract: https://pubmed.ncbi.nlm.nih.gov/9579474/

Kiernan JA. 1985. Axonal and vascular changes following injury to the rat’s optic nerve. J Anat 141:139-154.
Full Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1166396/pdf/janat00192-0143.pdf

Kitaoka Y, Kitaoka Y, Kwong JMK, Ross-Cisneros FN, Wang J, Tsai RK, Sadun AA, Lam TT. 2006. TNF-α-induced optic nerve degeneration and nuclear factor-κB. Invest Ophthalmol Vis Sci 47:1448-1457.
Full Text: https://doi.org/10.1167/iovs.05-0299

Lee EW, Render JA, Garner CD, Brady AN, Li LC. 1990. Unilateral degeneration of retina and optic nerve in Fischer-344 rats. Vet Pathol 27:439-444.
Abstract: http://vet.sagepub.com/content/27/6/439.short

Levkovitch-Verbin H. 2004. Animal models of optic nerve diseases. Eye 18:1066-1074.
Full Text: http://www.nature.com/eye/journal/v18/n11/full/6701576a.html

Mabuchi, F, Aihara M, Mackey MR, Lindsey JD, Weireb RN. 2003. Optic nerve damage in experimental mouse ocular hypertension. Invest Ophthalmol Vis Sci 44:4321-4330.
Full Text: https://doi.org/10.1167/iovs.03-0138

Maeda K, Sawada A, Matsuhara M, Nakai Y, Hara A, Yamamoto T. 2004. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat. Invest Ophthalmol Vis Res 45:851-855.
Full Text: https://doi.org/10.1167/iovs.03-0365

National Toxicology Program. 2011. NTP TR-567. Toxicology and Carcinogenesis Studies of Ginseng (CAS No. 50647-08-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP, Research Triangle Park, NC.
Abstract: https://ntp.niehs.nih.gov/go/34815

Ramos M, Reilly CM, Bolon B. 2011. Toxicological pathology of the retina and optic nerve. In: Fundamental Neuropathology for Pathologists and Toxicologists (Bolon B, Butt MT, eds). Wiley, Hoboken, NJ, 385-412.
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/9780470939956.ch24/summary

Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. 2006. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7:66-80.
Full Text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621073/

Smith RS, John SWM, Sundberg JP. 2002. Optic nerve and orbit. In: Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods (Smith RS, John SWM, Nishina PM, Sundberg JP, eds). CRC Press, Boca Raton, FL, 227-247.